Alignment Healthcare, Inc.

NasdaqGS:ALHC Rapport sur les actions

Capitalisation boursière : US$2.1b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Alignment Healthcare Croissance future

Future contrôle des critères 1/6

Alignment Healthcare devrait augmenter ses bénéfices et son chiffre d'affaires de 43.2% et de 18.8% par an respectivement. Le BPA devrait croître de de 43.8% par an. Le rendement des capitaux propres devrait être -81.4% dans 3 ans.

Informations clés

42.6%

Taux de croissance des bénéfices

42.8%

Taux de croissance du BPA

Healthcare croissance des bénéfices19.9%
Taux de croissance des recettes18.9%
Rendement futur des capitaux propres-87.5%
Couverture par les analystes

Good

Dernière mise à jour10 Oct 2024

Mises à jour récentes de la croissance future

Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Aug 04
Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Recent updates

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price

Oct 14
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Intrinsic Value Is Potentially 73% Above Its Share Price

Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely

Sep 12
Even With A 30% Surge, Cautious Investors Are Not Rewarding Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Performance Completely

Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?

Sep 10
Alignment Healthcare (NASDAQ:ALHC) Has Debt But No Earnings; Should You Worry?

Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Aug 04
Earnings Update: Here's Why Analysts Just Lifted Their Alignment Healthcare, Inc. (NASDAQ:ALHC) Price Target To US$9.55

Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost

Jul 18
Market Might Still Lack Some Conviction On Alignment Healthcare, Inc. (NASDAQ:ALHC) Even After 27% Share Price Boost

Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?

Jul 12
Is Now An Opportune Moment To Examine Alignment Healthcare, Inc. (NASDAQ:ALHC)?

An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued

Jun 20
An Intrinsic Calculation For Alignment Healthcare, Inc. (NASDAQ:ALHC) Suggests It's 26% Undervalued

The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More

May 30
The Market Lifts Alignment Healthcare, Inc. (NASDAQ:ALHC) Shares 37% But It Can Do More

Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?

Apr 19
Is Alignment Healthcare (NASDAQ:ALHC) Weighed On By Its Debt Load?

It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Feb 24
It's A Story Of Risk Vs Reward With Alignment Healthcare, Inc. (NASDAQ:ALHC)

Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Jan 18
Does Alignment Healthcare (NASDAQ:ALHC) Have A Healthy Balance Sheet?

Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Nov 08
Alignment Healthcare, Inc.'s (NASDAQ:ALHC) Subdued P/S Might Signal An Opportunity

Alignment Healthcare: Investors Should Align Themselves With Insiders

Oct 05

Alignment Healthcare announces 9M shares secondary offering

Sep 15

Alignment Healthcare completes debt refinancing

Sep 06

Alignment Healthcare: This Next-Generation Medicare Startup Is Fully Valued

Aug 22

Alignment Health Plan plans to expand into three Nevada counties

Jul 20

Alignment Healthcare Grows Revenue But Operating Losses Remain

May 17

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:ALHC - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/20263,970-7953959
12/31/20253,295-96297711
12/31/20242,630-128-28-811
6/30/20242,232-153-207-164N/A
3/31/20242,013-157-190-151N/A
12/31/20231,824-148-95-59N/A
9/30/20231,720-158-53-21N/A
6/30/20231,624-1634978N/A
3/31/20231,528-1462551N/A
12/31/20221,434-150-69-45N/A
9/30/20221,371-1405374N/A
6/30/20221,304-146-38-19N/A
3/31/20221,246-179-73-52N/A
12/31/20211,168-195-99-79N/A
9/30/20211,112-180-80-59N/A
6/30/20211,066-123-66-46N/A
3/31/20211,002-70-26-9N/A
12/31/2020959-23-88N/A
12/31/2019757-45-19N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: ALHC devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: ALHC devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: ALHC devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de ALHC ( 18.8% par an) devrait croître plus rapidement que le marché US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de ALHC ( 18.8% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: ALHC devrait être non rentable dans 3 ans.


Découvrir les entreprises en croissance